Benefits and risks of neoadjuvant therapy for liver metastases.
Nordlinger
Bernard
B
Benoist
Stéphane
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000473:pathology*; D005472:Fluorouracil; D006498:Hepatectomy; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery*; D020360:Neoadjuvant Therapy / Q000379:methods; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D005472:Fluorouracil